Dec 31 - Novavax Inc said on Friday it had submitted data to the U.S. Food and Drug Administration for emergency use authorization of its COVID-19 vaccine, with the company expecting to submit a formal request in one month. (Reporting by Leroy Leo in Bengaluru; Editing by Aditya Soni)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.76 USD | -3.45% | +10.96% | -0.83% |
05-06 | Novavax's Shareholder Shah Capital Urges Vote Against Re-Election of Directors | MT |
05-06 | Novavax's top shareholder Shah Capital ramps up efforts for board shakeup | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.83% | 664M | |
+22.81% | 46.81B | |
+47.07% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Novavax submits data to U.S. FDA for COVID-19 vaccine